Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen

Inclusion Criteria: * Documented HIV infection * 18 years of age or older and weigh at least 40 kg * Two plasma HIV RNA levels below the limit of quantification (one at least 90 days prior to the screening visit and one within 30 days of the patients baseline visit) * Currently receiving a standard-of-care HAART regimen with at least one agent being dosed twice-daily or more frequently Exclusion Criteria: * Pregnancy, breastfeeding or plans to become pregnant during the study period * Any prior documented virologic failure to one or more HAART regimens * Active AIDS-defining opportunistic infection or disease * Proven or suspected acute hepatitis within 30 days prior to study entry